Some of the content on this page has been created using generative AI.
What is it about?
This article examines the escalating issue of stimulant use disorder (StUD) amid rising overdose rates and the lack of FDA-approved pharmacological interventions. It highlights the intertwining of stimulant misuse with the opioid crisis and emphasizes the need for a biopsychosocial approach in treatment and management. The article notes the substantial increase in overdose deaths involving psychostimulants over the past two decades, partly due to adulteration with synthetic opioids like fentanyl. Despite research efforts, current pharmacological treatments for StUD remain ineffective, underscoring an urgent need for further investigation. The article advocates for a comprehensive strategy involving naloxone distribution, primary care education, and community-based interventions. It also emphasizes the importance of social and community connections in clinical treatment, advocating for family involvement, peer support, and avoidance of drug-associated environments to enhance recovery outcomes.
Featured Image
Why is it important?
This Perspective highlights the growing concern of stimulant use disorder (StUD) in the context of rising overdose rates and limited treatment options. It underscores the need for a comprehensive biopsychosocial approach to address this issue, as current pharmacological interventions are inadequate. The article emphasizes the importance of integrating social and community support in treatment and prevention strategies. Key Takeaways: 1. The Perspective discusses the lack of FDA-approved pharmacological treatments for StUD, contrasting it with other substance use disorders where medication-assisted treatment is standard. This highlights a significant gap in clinical care that requires urgent research and development to identify effective pharmacologic interventions. 2. It emphasizes the critical role of primary care providers in identifying and managing StUD, advocating for enhanced education and tools such as the SBIRT model to improve screening and referral practices. This is essential for supporting patients who may have limited access to specialized care. 3. The article outlines the significance of incorporating social and community connections into treatment plans. By engaging families, social networks, and peer recovery support services, the Perspective suggests that a more holistic and supportive environment can enhance recovery outcomes and reduce relapse rates.
AI notice
Read the Original
This page is a summary of: Emerging Biopsychosocial Models of Care for Psychostimulant Disorder Prevention and Treatment, Premier Journal of Psychology, January 2025, Premier Science,
DOI: 10.70389/pjp.100003.
You can read the full text:
Contributors
Be the first to contribute to this page







